Advanced search
Publication Cover
The World Journal of Biological Psychiatry Volume 8, 2007 - Issue 2
Submit an article Journal homepage
7,008
Views
273
CrossRef citations to date
0
Altmetric
REVIEW

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care

Professor Michael Bauer Department of Psychiatry and Psychotherapy, University Hospital, Technische Universität Dresden, Dresden, Germany; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior Los Angeles, University of California Los Angeles (UCLA), Los Angeles, CA, USACorrespondence[email protected]
, PhD , MD,
Tom Bschor Department of Psychiatry and Psychotherapy, Jewish Hospital of Berlin, Berlin, Germany
,
Andrea Pfennig Department of Psychiatry and Psychotherapy, Charité – Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany
,
Peter C. Whybrow Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior Los Angeles, University of California Los Angeles (UCLA), Los Angeles, CA, USA
,
Jules Angst Department of Psychiatry, University of Zürich, Zürich, Switzerland
,
Marcio Versiani Department of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brasil
,
Hans-Jürgen Möller Department of Psychiatry, Ludwig-Maximilians-University, , Munich, Germany
,
WFSBP Task Force on Unipolar Depressive Disorders Department of Psychiatry and Psychotherapy, University Hospital, Technische Universität Dresden, Dresden, Germany
,
Professor Michael Bauer Department of Psychiatry and Psychotherapy, University Hospital, Technische Universität Dresden, Dresden, Germany; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior Los Angeles, University of California Los Angeles (UCLA), Los Angeles, CA, USACorrespondence[email protected]
, PhD , MD,
Tom Bschor Department of Psychiatry and Psychotherapy, Jewish Hospital of Berlin, Berlin, Germany
,
Andrea Pfennig Department of Psychiatry and Psychotherapy, Charité – Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany
,
Peter C. Whybrow Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior Los Angeles, University of California Los Angeles (UCLA), Los Angeles, CA, USA
,
Jules Angst Department of Psychiatry, University of Zürich, Zürich, Switzerland
,
Marcio Versiani Department of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brasil
,
Hans-Jürgen Möller Department of Psychiatry, Ludwig-Maximilians-University, , Munich, Germany
&
WFSBP Task Force on Unipolar Depressive Disorders Department of Psychiatry and Psychotherapy, University Hospital, Technische Universität Dresden, Dresden, Germany
 show all
Pages 67-104 | Published online: 12 Jul 2009

Citations (273)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (32)

Akiyoshi Okada. (2022) The health insurance system and psychoanalytic psychotherapy in Japan: the association with evidence-based practice. Psychoanalytic Psychotherapy 36:4, pages 288-299.
Read now
Seetal Dodd, Michael Bauer, Andre F. Carvalho, Harris Eyre, Maurizio Fava, Siegfried Kasper, Sidney H. Kennedy, Jon-Paul Khoo, Carlos Lopez Jaramillo, Gin S. Malhi, Roger S. McIntyre, Philip B. Mitchell, Angela Marianne Paredes Castro, Aswin Ratheesh, Emanuel Severus, Trisha Suppes, Madhukar H. Trivedi, Michael E. Thase, Lakshmi N. Yatham, Allan H. Young & Michael Berk. (2021) A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough?. The World Journal of Biological Psychiatry 22:7, pages 483-494.
Read now
Meredith Blampied, Caroline Bell, Claire Gilbert & Julia J. Rucklidge. (2020) Broad spectrum micronutrient formulas for the treatment of symptoms of depression, stress, and/or anxiety: a systematic review. Expert Review of Neurotherapeutics 20:4, pages 351-371.
Read now
John M Zajecka, Arielle D Stanford, Asli Memisoglu, William F Martin & Sanjeev Pathak. (2019) Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3). Neuropsychiatric Disease and Treatment 15, pages 795-808.
Read now
Siegfried Kasper. (2019) A thank-you note from the Chief-Editor. The World Journal of Biological Psychiatry 20:4, pages 254-257.
Read now
Tempei Otsubo, Yoshinori Watanabe, Seiji Hongo, Mikichika Inoue, Kimiko Akimoto, Ken Murakami, Ryutaro Takahashi & Toshiaki Kikuchi. (2018) Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study. Neuropsychiatric Disease and Treatment 14, pages 955-966.
Read now
Seetal Dodd, Philip B. Mitchell, Michael Bauer, Lakshmi Yatham, Allan H. Young, Sidney H. Kennedy, Lana Williams, Trisha Suppes, Carlos Lopez Jaramillo, Madhukar H. Trivedi, Maurizio Fava, A. John Rush, Roger S. McIntyre, Michael E. Thase, Raymond W. Lam, Emanuel Severus, Siegfried Kasper & Michael Berk. (2018) Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement. The World Journal of Biological Psychiatry 19:5, pages 330-348.
Read now
Tom Bschor & Laura L. Kilarski. (2016) Are antidepressants effective? A debate on their efficacy for the treatment of major depression in adults. Expert Review of Neurotherapeutics 16:4, pages 367-374.
Read now
Masaki Kato, Toshifumi Kimura, Takeshi Kimura & Terufumi Hara. (2015) Safety and effectiveness of controlled-release paroxetine in routine clinical practice: results of a postmarketing surveillance study of patients with depression. Neuropsychiatric Disease and Treatment 11, pages 435-452.
Read now
Hans-Jürgen Möller, Koen Demyttenaere, Bengt Olausson, Johan Szamosi, Ellis Wilson, David Hosford, Geoffrey Dunbar, Raj Tummala & Hans Eriksson. (2015) Two Phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy. The World Journal of Biological Psychiatry 16:7, pages 483-501.
Read now
Mariesha Jaffray, Amanda H. Cardy, Ian C. Reid & Isobel M. Cameron. (2014) Why do patients discontinue antidepressant therapy early? A qualitative study. European Journal of General Practice 20:3, pages 167-173.
Read now
Richard Weisler & Roger S McIntyre. (2013) The role of extended-release quetiapine fumarate monotherapy in the treatment of patients with major depressive disorder. Expert Review of Neurotherapeutics 13:11, pages 1161-1182.
Read now
Richard Weisler, Roger S McIntyre & Michael Bauer. (2013) Extended-release quetiapine fumarate in the treatment of patients with major depressive disorder: adjunct therapy. Expert Review of Neurotherapeutics 13:11, pages 1183-1200.
Read now
Ken Wada, Takanobu Sasaki, Hiroaki Jitsuiki & Yoshiyuki Takaishi. (2013) One-year outcomes of unipolar depression patients with manic or hypomanic switch during acute antidepressant treatment. International Journal of Psychiatry in Clinical Practice 17:3, pages 219-222.
Read now
Martin Bares, Tomas Novak, Miloslav Kopecek, Pavla Stopkova, Jan Cermak, Jiri Kozeny & Cyril Höschl. (2013) Antidepressant monotherapy compared with combinations of antidepressants in the treatment of resistant depressive patients: A randomized, open-label study. International Journal of Psychiatry in Clinical Practice 17:1, pages 35-43.
Read now
Alain Gérard, François Liard, Anne Crochard, Sylvia Goni & Bruno Millet. (2012) Disability in patients consulting for anxiety or mood disorders in primary care: response to antidepressant treatment. Neuropsychiatric Disease and Treatment 8, pages 605-614.
Read now
E. Aguglia, R. Ravasio, M. Simonetti, S. Pecchioli & F. Mazzoleni. (2012) Use and treatment modalities for SSRI and SNRI antidepressants in Italy during the period 2003–2009. Current Medical Research and Opinion 28:9, pages 1475-1484.
Read now
Stephan Köhler, Sabine Hoffmann, Theresa Unger, Bruno Steinacher & Thomas Fydrich. (2012) Adherence to guidelines and effectiveness of inpatient treatment for unipolar depression. International Journal of Psychiatry in Clinical Practice 16:2, pages 103-112.
Read now
Christian Scharinger, Ulrich Rabl, Lukas Pezawas & Siegfried Kasper. (2011) The genetic blueprint of major depressive disorder: Contributions of imaging genetics studies. The World Journal of Biological Psychiatry 12:7, pages 474-488.
Read now
Anastasios Konstantinidis, Klaus Martiny, Per Bech & Siegfried Kasper. (2011) A comparison of the Major Depression Inventory (MDI) and the Beck Depression Inventory (BDI) in severely depressed patients. International Journal of Psychiatry in Clinical Practice 15:1, pages 56-61.
Read now
Siegfried Kasper & Gerald Pail. (2010) Milnacipran: a unique antidepressant?. Neuropsychiatric Disease and Treatment 6:sup1, pages 23-31.
Read now
Susan L McElroy, Anna Guerdjikova, Nicole Mori & Paul E Keck Jr. (2010) Therapeutic potential of new second generation antipsychotics for major depressive disorder. Expert Opinion on Investigational Drugs 19:12, pages 1527-1544.
Read now
Martin Bares, Tomas Novak, Miloslav Kopecek, Pavla Stopkova & Cyril Höschl. (2010) Antidepressant monotherapy and combination of antidepressants in the treatment of resistant depression in current clinical practice: A retrospective study. International Journal of Psychiatry in Clinical Practice 14:4, pages 303-308.
Read now
Dirk Wedekind, Stefan Jacobs, Iris Karg, Christel Luedecke, Udo Schneider, Konrad Cimander, Pierre Baumann, Eckart Ruether, Wolfgang Poser & Ursula Havemann-Reinecke. (2010) Psychiatric comorbidity and additional abuse of drugs in maintenance treatment with l- and d,l-methadone. The World Journal of Biological Psychiatry 11:2-2, pages 390-399.
Read now
Subho Chakrabarti, Sandeep Grover & Rajendra Rajagopal. (2010) Electroconvulsive therapy: A review of knowledge, experience and attitudes of patients concerning the treatment. The World Journal of Biological Psychiatry 11:3, pages 525-537.
Read now
Ellen Piek, Klaas van der Meer & Willem A. Nolen. (2010) Guideline recommendations for long-term treatment of depression with antidepressants in primary care—a critical review. European Journal of General Practice 16:2, pages 106-112.
Read now
Tom Bschor. (2010) Therapy-resistant depression. Expert Review of Neurotherapeutics 10:1, pages 77-86.
Read now
Andrew F. Leuchter, Ian A. Cook, Aimee M. Hunter & Alexander S. Korb. (2009) A new paradigm for the prediction of antidepressant treatment response. Dialogues in Clinical Neuroscience 11:4, pages 435-446.
Read now
Arif Khan. (2009) Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression. Expert Opinion on Investigational Drugs 18:11, pages 1753-1764.
Read now
Hans-Jürgen Möller. (2009) Antidepressants: Controversies about their efficacy in depression, their effect on suicidality and their place in a complex psychiatric treatment approach. The World Journal of Biological Psychiatry 10:3, pages 180-195.
Read now
Borwin Bandelow, Joseph Zohar, Siegfried Kasper & Hans-Jürgen Möller. (2008) How to grade categories of evidence. The World Journal of Biological Psychiatry 9:4, pages 242-247.
Read now
. (2008) Abstracts. International Journal of Psychiatry in Clinical Practice 12:4, pages 316-349.
Read now

Articles from other publishers (241)

Yurong Sun, Yingling Hou, Xinyi Wang, Huan Wang, Rui Yan, Li Xue, Zhijian Yao & Qing Lu. (2024) Links among genetic variants and hierarchical brain structural and functional networks for antidepressant treatment: A multivariate study. Brain Research 1822, pages 148661.
Crossref
Jaqueline Kalleian Eserian, Vinícius Paccola Blanco, Lucildes Pita Mercuri, Jivaldo do Rosario Matos & José Carlos Fernandes Galduróz. (2023) Current strategies for tapering psychiatric drugs: Differing recommendations, impractical doses, and other barriers. Psychiatry Research 329, pages 115537.
Crossref
Florian Seemüller, Rebecca Schennach, Richard Musil, Michael Obermeier, Mazda Adli, Michael Bauer, Peter Brieger, Gerd Laux, Wolfgang Gaebel, Peter Falkai, Michael Riedel & Hans-Jürgen Möller. (2023) A factor analytic comparison of three commonly used depression scales (HAMD, MADRS, BDI) in a large sample of depressed inpatients. BMC Psychiatry 23:1.
Crossref
Julian Maciaszek, Tomasz Pawłowski, Tomasz Hadryś & Błażej Misiak. (2023) Baseline depressive symptoms as predictors of efficacy and tolerability of the treatment with duloxetine: a network analysis approach. Frontiers in Psychiatry 14.
Crossref
Sahar Obeïd, Hala Sacre & Souheil Hallit. 2023. Handbook of Medical and Health Sciences in Developing Countries. Handbook of Medical and Health Sciences in Developing Countries 1 17 .
Anders Sørensen, Karsten Juhl Jørgensen & Klaus Munkholm. (2022) Description of antidepressant withdrawal symptoms in clinical practice guidelines on depression: A systematic review. Journal of Affective Disorders 316, pages 177-186.
Crossref
Saira A. Weinzimmer, Amy R. Goetz, Andrew G. Guzick, Lynn M. Hana, Sandra L. Cepeda, Sophie C. Schneider, Sarah M. Kennedy, Gifty N. Amos Nwankwo, Catherine C. Christian, Ashley M. Shaw, Alison Salloum, Asim A. Shah, Wayne K. Goodman, Jill Ehrenreich-May & Eric A. Storch. (2022) Primary Outcomes for Adults Receiving the Unified Protocol after Hurricane Harvey in an Integrated Healthcare Setting. Community Mental Health Journal 58:8, pages 1522-1534.
Crossref
Thilo Friehs, Winfried Rief, Julia A. Glombiewski, Julia Haas & Tobias Kube. (2022) Deceptive and non-deceptive placebos to reduce sadness: A five-armed experimental study. Journal of Affective Disorders Reports 9, pages 100349.
Crossref
Jieping Lin, Fa Ling, Ping Huang, Min Chen, Min Song, Kangrong Lu & Wanshan Wang. (2022) The Development of GABAergic Network in Depression in Recent 17 Years: A Visual Analysis Based on CiteSpace and VOSviewer. Frontiers in Psychiatry 13.
Crossref
Bo Liu, Hongli Chang, Kang Peng & Xuenan Wang. (2022) An End-to-End Depression Recognition Method Based on EEGNet. Frontiers in Psychiatry 13.
Crossref
Young Sup Woo, Won-Myong Bahk, Jeong Seok Seo, Young-Min Park, Won Kim, Jong-Hyun Jeong, Se-Hoon Shim, Jung Goo Lee, Seung-Ho Jang, Chan-Mo Yang, Sheng-Min Wang, Myung Hun Jung, Hyung Mo Sung, Il Han Choo, Bo-Hyun Yoon, Sang-Yeol Lee, Duk-In Jon & Kyung Joon Min. (2022) The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment Guidelines. Clinical Psychopharmacology and Neuroscience 20:1, pages 37-50.
Crossref
Florian Seemüller, Miriam Kolter, Richard Musil, Rebecca Schennach, Mazda Adli, Michael Bauer, Peter Brieger, Gerd Laux, Michael Riedel, Peter Falkai, Hans-Jürgen Möller & Frank Padberg. (2022) Chronic vs non-chronic depression in psychiatric inpatient care - Data from a large naturalistic multicenter trial. Journal of Affective Disorders 299, pages 73-84.
Crossref
Peter J. Na, Elizabeth Ralevski, Oluwole Jegede, Aaron Wolfgang & Ismene L. Petrakis. (2022) Depression and/or PTSD Comorbidity Affects Response to Antidepressants in Those With Alcohol Use Disorder. Frontiers in Psychiatry 12.
Crossref
AlokV Kulkarni. (2022) A head-to-head randomised controlled trial of aripiprazole versus quetiapine as augmenting agents in treatment-resistant depression. Advances in Human Biology 12:3, pages 307.
Crossref
Anders Sørensen, Karsten Juhl Jørgensen & Klaus Munkholm. (2022) Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review. Therapeutic Advances in Psychopharmacology 12, pages 204512532110676.
Crossref
Ryuji Furihata, Rei Otsuki, Naomi Hasegawa, Takashi Tsuboi, Shusuke Numata, Norio Yasui-Furukori, Hiroko Kashiwagi, Hikaru Hori, Shinichiro Ochi, Hiroyuki Muraoka, Toshiaki Onitsuka, Hiroshi Komatsu, Masahiro Takeshima, Akitoyo Hishimoto, Tatsuya Nagasawa, Yoshikazu Takaesu, Toshinori Nakamura, Takeshi Asami, Kenichiro Miura, Junya Matsumoto, Kazutaka Ohi, Yuka Yasuda, Hitoshi Iida, Kazuyoshi Ogasawara, Naoki Hashimoto, Kayo Ichihashi, Hisashi Yamada, Koichiro Watanabe, Ken Inada & Ryota Hashimoto. (2022) Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study. Sleep Medicine 89, pages 23-30.
Crossref
Rabie Karrouri, Zakaria Hammani, Roukaya Benjelloun & Yassine Otheman. (2021) Major depressive disorder: Validated treatments and future challenges. World Journal of Clinical Cases 9:31, pages 9350-9367.
Crossref
Gina R. A. Ferrari, Marie-Anne Vanderhasselt, Mike Rinck, Ineke Demeyer, Rudi De Raedt, Sylvia Beisel, Johannes Lindenmeyer & Eni S. Becker. (2021) A Cognitive Control Training as Add-On Treatment to Usual Care for Depressed Inpatients. Cognitive Therapy and Research 45:5, pages 929-943.
Crossref
Daniëlle E. J. Starreveld, Laurien A. Daniels, Jacobien M. Kieffer, Heiddis B. Valdimarsdottir, Jessie de Geus, Mirthe Lanfermeijer, Eus J. W. van Someren, G. Esther A. Habers, Jos A. Bosch, Cécile P. M. Janus, Dick Johan van Spronsen, Roel J. de Weijer, Erik W. A. Marijt, Eva de Jongh, Josée M. Zijlstra, Lara H. Böhmer, Margreet Houmes, Marie José Kersten, Catharina M. Korse, Huub H. van Rossum, William H. Redd, Susan K Lutgendorf, Sonia Ancoli-Israel, Flora E. van Leeuwen & Eveline M. A. Bleiker. (2021) Light Therapy for Cancer-Related Fatigue in (Non-)Hodgkin Lymphoma Survivors: Results of a Randomized Controlled Trial. Cancers 13:19, pages 4948.
Crossref
Grzegorz Ślifirski, Marek Król & Jadwiga Turło. (2021) 5-HT Receptors and the Development of New Antidepressants. International Journal of Molecular Sciences 22:16, pages 9015.
Crossref
Ibrahim Mohammed Badamasi, Munn Sann Lye, Normala Ibrahim, Nurul Asyikin Abdul Razaq, King Hwa Ling & Johnson Stanslas. (2021) Serotonergic receptor gene polymorphism and response to selective serotonin reuptake inhibitors in ethnic Malay patients with first episode of major depressive disorder. The Pharmacogenomics Journal 21:4, pages 498-509.
Crossref
Emma Komulainen, Enrico Glerean, Roope Heikkilä, Lauri Nummenmaa, Tuukka T. Raij, Erkki Isometsä & Jesper Ekelund. (2021) Escitalopram enhances synchrony of brain responses during emotional narratives in patients with major depressive disorder. NeuroImage 237, pages 118110.
Crossref
Tomohiro Nakao, Keitaro Murayama, Sho Takahashi, Mami Kayama, Daisuke Nishi, Toru Horinouchi, Nozomu Oya & Hironori Kuga. (2021) Mental Health Difficulties and Countermeasures during the Coronavirus Disease Pandemic in Japan: A Nationwide Questionnaire Survey of Mental Health and Psychiatric Institutions. International Journal of Environmental Research and Public Health 18:14, pages 7318.
Crossref
Manoela V. Fogaça, Min Wu, Chan Li, Xiao-Yuan Li, Marina R. Picciotto & Ronald S. Duman. (2020) Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses. Molecular Psychiatry 26:7, pages 3277-3291.
Crossref
Yuan Wang, Jiang-Hong Gu, Ling Liu, Yue Liu, Wen-Qian Tang, Chun-Hui Ji, Wei Guan, Xin-Yi Zhao, Ying-Fang Sun, Da-Wei Xu & Bo Jiang. (2021) Hippocampal PPARα Plays a Role in the Pharmacological Mechanism of Vortioxetine, a Multimodal-Acting Antidepressant. Frontiers in Pharmacology 12.
Crossref
Alexander Sartorius, Juliane Beuschlein, Dmitry Remennik, Anna-Maria Pfeifer, Sebastian Karl, Jan Malte Bumb, Suna Su Aksay, Laura Kranaster & Christoph Janke. (2020) Empirical ratio of the combined use of S-ketamine and propofol in electroconvulsive therapy and its impact on seizure quality. European Archives of Psychiatry and Clinical Neuroscience 271:3, pages 457-463.
Crossref
Xiao-Yu Yang, Zhao-Liang Ma, Daniel R Storm, Hong Cao & Yu-Qiu Zhang. (2021) Selective ablation of type 3 adenylyl cyclase in somatostatin-positive interneurons produces anxiety- and depression-like behaviors in mice. World Journal of Psychiatry 11:2, pages 35-49.
Crossref
Xiao-Yu Yang, Zhao-Liang Ma, Daniel R Storm, Hong Cao & Yu-Qiu Zhang. (2021) Selective ablation of type 3 adenylyl cyclase in somatostatin-positive interneurons produces anxiety- and depression-like behaviors in mice. World Journal of Psychiatry 11:2, pages 21-35.
Crossref
Jan Engelmann, Stefanie Wagner, Andreas Solheid, David P. Herzog, Nadine Dreimüller, Marianne B. Müller, André Tadić, Christoph Hiemke & Klaus Lieb. (2021) Tolerability of High-Dose Venlafaxine After Switch From Escitalopram in Nonresponding Patients With Major Depressive Disorder. Journal of Clinical Psychopharmacology 41:1, pages 62-66.
Crossref
Wataru Ukai, Kenta Deriha, Eri Hashimoto & Chiaki Kawanishi. 2021. The Neuroscience of Depression. The Neuroscience of Depression 369 379 .
Héloïse Delavenne, Frederico Duarte Garcia, Nathalie Giraudeau, Sandrine Louchart, Lynda Zarrou, Humberto Correa & Florence Thibaut. (2020) Intensive supportive ambulatory aftercare may increase adherence to treatment and decrease depressive symptoms in patients after a suicide attempt. French Journal of Psychiatry 2-4, pages 39-47.
Crossref
Julia W. Haas, Winfried Rief, Julia A. Glombiewski, Alexander Winkler & Bettina K. Doering. (2020) Expectation-induced placebo effect on acute sadness in women with major depression: An experimental investigation. Journal of Affective Disorders 274, pages 920-928.
Crossref
Maurizio Fava, Michael E. Thase, Madhukar H. Trivedi, Elliot Ehrich, William F. Martin, Asli Memisoglu, Narinder Nangia, Arielle D. Stanford, Miao Yu & Sanjeev Pathak. (2018) Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies. Molecular Psychiatry 25:7, pages 1580-1591.
Crossref
Xiaotong Wang, Haixiong Lin, Xiumin Jiang, Minna Ma, Dandan Shi, Chun Fan, Yin Shao, Shengwei Wu, Lin Yu, Danian Li, Jun He & Yongjun Chen. (2020) Effect of Electroacupuncture and Counseling on Sub-Threshold Depression: A Study Protocol for a Multicenter Randomized Controlled Trial. Frontiers in Psychiatry 11.
Crossref
Anna Stippl, Fatma Nur Kirkgöze, Malek Bajbouj & Simone Grimm. (2020) Differential Effects of Electroconvulsive Therapy in the Treatment of Major Depressive Disorder. Neuropsychobiology 79:6, pages 408-416.
Crossref
Karen A. van Haaften, Emma K. Grigg, Cheryl Kolus, Lynette Hart & Lori R. Kogan. (2020) A survey of dog owners’ perceptions on the use of psychoactive medications and alternatives for the treatment of canine behavior problems. Journal of Veterinary Behavior 35, pages 27-33.
Crossref
Maria Uscinska, Andrea Polla Mattiot & Silvio Bellino. 2019. Behavioral Neuroscience. Behavioral Neuroscience.
Maximilian Pilhatsch, Thomas J Stamm, Petra Stahl, Ute Lewitzka, Anne Berghöfer, Cathrin Sauer, Michael Gitlin, Mark A. Frye, Peter C. Whybrow & Michael Bauer. (2019) Treatment of bipolar depression with supraphysiologic doses of levothyroxine: a randomized, placebo-controlled study of comorbid anxiety symptoms. International Journal of Bipolar Disorders 7:1.
Crossref
Michael E. Thase, Arielle D. Stanford, Asli Memisoglu, William Martin, Amy Claxton, J. Alexander Bodkin, Madhukar H. Trivedi, Maurizio Fava, Miao Yu & Sanjeev Pathak. (2019) Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder. Neuropsychopharmacology 44:13, pages 2268-2276.
Crossref
Daniela Adamo, Giuseppe Pecoraro, Massimo Aria, Gianfranco Favia & Michele Davide Mignogna. (2019) Vortioxetine in the Treatment of Mood Disorders Associated with Burning Mouth Syndrome: Results of an Open-Label, Flexible-Dose Pilot Study. Pain Medicine.
Crossref
Rebecca Schennach, Michael Obermeier, Ilja Spellmann, Florian Seemüller, Richard Musil, Markus Jäger, Max Schmauss, Gerd Laux, Herbert Pfeiffer, Dieter Naber, Lutz G. Schmidt, Wolfgang Gaebel, Joachim Klosterkötter, Isabella Heuser, Michael Bauer, Mazda Adli, Joachim Zeiler, Wolfram Bender, Klaus-Thomas Kronmüller, Marcus Ising, Peter Brieger, Wolfgang Maier, Matthias R. Lemke, Eckart Rüther, Stefan Klingberg, Markus Gastpar, Hans-Jürgen Möller & Michael Riedel. (2019) Remission in schizophrenia — What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression. Schizophrenia Research 209, pages 185-192.
Crossref
Kellie J. Goodlet, Monika T. Zmarlicka & Alyssa M. Peckham. (2018) Drug–drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs. CNS Spectrums 24:03, pages 287-312.
Crossref
Domenico De Donatis, Vincenzo Florio, Stefano Porcelli, Alois Saria, Laura Mercolini, Alessandro Serretti & Andreas Conca. (2019) Duloxetine plasma level and antidepressant response. Progress in Neuro-Psychopharmacology and Biological Psychiatry 92, pages 127-132.
Crossref
Manoela V. Fogaça & Ronald S. Duman. (2019) Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions. Frontiers in Cellular Neuroscience 13.
Crossref
Dandan Chen, Weijia Sun, Na Liu, Jie Wang, Pingping Guo, Xuehui Zhang & Wei Zhang. (2019) Effects of nonpharmacological interventions on depressive symptoms and depression among nursing students: A systematic review and meta-analysis. Complementary Therapies in Clinical Practice 34, pages 217-228.
Crossref
. 2019. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen 1 119 .
Tonghui Su, Yi Lu, Yang Geng, Wei Lu & Yelin Chen. (2019) How could N-Methyl-D-Aspartate Receptor Antagonists Lead to Excitation Instead of Inhibition?. Brain Science Advances 4:2, pages 73-98.
Crossref
Jitsuki Sawamura, Jun Ishigooka & Katsuji Nishimura. (2018) Re-evaluation of the definition of remission on the 17-item Hamilton Depression Rating Scale based on recovery in health-related quality of life in an observational post-marketing study. Health and Quality of Life Outcomes 16:1.
Crossref
Elena Y. Zelina, Tatyana A. Nevolina, Ludmila N. Sorotskaja, Dmitry A. Skvortsov, Igor V. Trushkov & Maxim G. Uchuskin. (2018) A General Synthetic Route to Isomeric Pyrrolo[1,2- x ][1,4]diazepinones . The Journal of Organic Chemistry 83:19, pages 11747-11757.
Crossref
Qing-E Zhang, Fu-Chun Zhou, Ling Zhang, Chee H. Ng, Gabor S. Ungvari, Gang Wang & Yu-Tao Xiang. (2018) Knowledge and attitudes of older psychiatric patients and their caregivers towards electroconvulsive therapy. Psychogeriatrics 18:5, pages 343-350.
Crossref
Beata Ryszewska-Pokraśniewicz, Anna Mach, Michał Skalski, Piotr Januszko, Zbigniew Wawrzyniak, Ewa Poleszak, Gabriel Nowak, Andrzej Pilc & Maria Radziwoń-Zaleska. (2018) Effects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response. Nutrients 10:8, pages 1014.
Crossref
Masahiro Banno, Yudai Harada, Masashi Taniguchi, Ryo Tobita, Hiraku Tsujimoto, Yasushi Tsujimoto, Yuki Kataoka & Akiko Noda. (2018) Exercise can improve sleep quality: a systematic review and meta-analysis. PeerJ 6, pages e5172.
Crossref
Rudolf A. Werner, Ryohei Kobayashi, Mehrbod Som Javadi, Zoe Köck, Hiroshi Wakabayashi, Stefan Unterecker, Kenichi Nakajima, Constantin Lapa, Andreas Menke & Takahiro Higuchi. (2018) Impact of Novel Antidepressants on Cardiac 123 I-Metaiodobenzylguanidine Uptake: Experimental Studies on SK-N-SH Cells and Healthy Rabbits . Journal of Nuclear Medicine 59:7, pages 1099-1103.
Crossref
Xue Zhao, Jing Ma, Shiyou Wu, Iris Chi & Zhenggang Bai. (2018) Light therapy for older patients with non-seasonal depression: A systematic review and meta-analysis. Journal of Affective Disorders 232, pages 291-299.
Crossref
Antonio E. Nardi, João Romildo Bueno & José Carlos Appolinario. (2018) In memoriam, Professor Marcio Versiani. Jornal Brasileiro de Psiquiatria 67:1, pages 1-2.
Crossref
Richard Musil, Florian Seemüller, Sebastian Meyer, Ilja Spellmann, Mazda Adli, Michael Bauer, Klaus-Thomas Kronmüller, Peter Brieger, Gerd Laux, Wolfram Bender, Isabella Heuser, Robert Fisher, Wolfgang Gaebel, Rebecca Schennach, Hans-Jürgen Möller & Michael Riedel. (2018) Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder. International Journal of Methods in Psychiatric Research 27:1, pages e1569.
Crossref
Jeong Seok Seo, Won-Myong Bahk, Hee Ryung Wang, Young Sup Woo, Young-Min Park, Jong-Hyun Jeong, Won Kim, Se-Hoon Shim, Jung Goo Lee, Duk-In Jon & Kyung Joon Min. (2018) Korean Medication Algorithm for Depressive Disorders 2017: Third Revision. Clinical Psychopharmacology and Neuroscience 16:1, pages 67-87.
Crossref
Bartosz Zurowski & Fritz Hohagen. 2018. Lehrbuch der Verhaltenstherapie, Band 1. Lehrbuch der Verhaltenstherapie, Band 1 249 269 .
Yi Zhang, Yuting Wang, Hui Lei, Lei Wang, Liang Xue, Xin Wang & Xiongzhao Zhu. (2017) Optimized animal model to mimic the reality of stress-induced depression in the clinic. BMC Psychiatry 17:1.
Crossref
Mei Bai, Xiongzhao Zhu, Li Zhang, Yi Zhang, Liang Xue, Yuting Wang, Mingtian Zhong & Xiuwu Zhang. (2017) Divergent anomaly in mesocorticolimbic dopaminergic circuits might be associated with different depressive behaviors, an animal study. Brain and Behavior 7:10, pages e00808.
Crossref
Hee Ryung Wang, Won-Myong Bahk, Jeong Seok Seo, Young Sup Woo, Young-Min Park, Jong-Hyun Jeong, Won Kim, Se-Hoon Shim, Jung Goo Lee, Duk-In Jon & Kyung Joon Min. (2017) Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines. Clinical Psychopharmacology and Neuroscience 15:3, pages 199-209.
Crossref
CW Ng, CH How & YP Ng. (2017) Managing depression in primary care. Singapore Medical Journal 58:8, pages 459-466.
Crossref
Hitoshi Sakurai, Takefumi Suzuki, Kimio Yoshimura, Masaru Mimura & Hiroyuki Uchida. (2017) Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data. Psychopharmacology 234:16, pages 2453-2461.
Crossref
Wolfgang Novak, Gabriele Sachs & Andreas Erfurth. (2017) Diagnostik und Therapie depressiver StörungenDiagnosis and therapy of depressive disorders. psychopraxis. neuropraxis 20:3, pages 124-129.
Crossref
Jie Fan, Bingjin Li, Tongtong Ge, Zhuo Zhang, Jiayin Lv, Jing Zhao, Pu Wang, Wei Liu, Xuefeng Wang, Katarzyna Mlyniec & Ranji Cui. (2017) Berberine produces antidepressant-like effects in ovariectomized mice. Scientific Reports 7:1.
Crossref
Catherine J Harmer, Ronald S Duman & Philip J Cowen. (2017) How do antidepressants work? New perspectives for refining future treatment approaches. The Lancet Psychiatry 4:5, pages 409-418.
Crossref
Benny Bang-Andersen, Klaus P. Bøgesø, Jan Kehler & Connie Sánchez. 2017. Transporters as Drug Targets. Transporters as Drug Targets 21 52 .
Wolfgang Novak & Andreas Erfurth. (2017) Therapie depressiver Störungen mit selektiven Serotonin-Rückaufnahme-Inhibitoren (SSRI)Treatment of depressive disorders with selective serotonin reuptake inhibitors (SSRI). psychopraxis. neuropraxis 20:1, pages 28-41.
Crossref
M Spies, C Kraus, N Geissberger, B Auer, M Klöbl, M Tik, I-L Stürkat, A Hahn, M Woletz, D M Pfabigan, S Kasper, C Lamm, C Windischberger & R Lanzenberger. (2017) Default mode network deactivation during emotion processing predicts early antidepressant response. Translational Psychiatry 7:1, pages e1008-e1008.
Crossref
Glenda MacQueen, Pasqualina Santaguida, Homa Keshavarz, Natalia Jaworska, Mitchell Levine, Joseph Beyene & Parminder Raina. (2016) Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults. The Canadian Journal of Psychiatry 62:1, pages 11-23.
Crossref
Klaas M. Huijbregts, AdriaanW. Hoogendoorn, Paulien Slottje, Anton J.L.M. van Balkom & Neeltje M. Batelaan. (2017) Long-Term and Short-Term Antidepressant Use in General Practice: Data from a Large Cohort in the Netherlands. Psychotherapy and Psychosomatics 86:6, pages 362-369.
Crossref
. 2017. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen 1 111 .
Wojciech Jernajczyk, Paweł Gosek, Miroslaw Latka, Klaudia Kozlowska, Łukasz Święcicki & Bruce J. West. 2017. Influenza and Respiratory Care. Influenza and Respiratory Care 79 94 .
Tara M. Rutter, Annesa Flentje, James W. Dilley, Suzanne Barakat, Nancy H. Liu, Margaret S. Gross, Ricardo F. Muñoz & Yan Leykin. (2016) Sexual orientation and treatment-seeking for depression in a multilingual worldwide sample. Journal of Affective Disorders 206, pages 87-93.
Crossref
Ann-Charlotte Mårdby, Linus Schiöler, Karolina Andersson Sundell, Pernilla Bjerkeli, Eva Lesén & Anna K. Jönsson. (2016) Adherence to antidepressants among women and men described with trajectory models: a Swedish longitudinal study. European Journal of Clinical Pharmacology 72:11, pages 1381-1389.
Crossref
Renske C Bosman, Klaas M Huijbregts, Peter FM Verhaak, Henricus G Ruhé, Harm WJ van Marwijk, Anton JLM van Balkom & Neeltje M Batelaan. (2016) Long-term antidepressant use: a qualitative study on perspectives of patients and GPs in primary care. British Journal of General Practice 66:651, pages e708-e719.
Crossref
Kurt Stastka. (2016) Psychotherapie bei DepressionPsychotherapy for depression. psychopraxis. neuropraxis 19:5, pages 186-191.
Crossref
Alina Surís, Nicholas Holder, Ryan Holliday & Matthew Clem. (2016) Psychometric validation of the 16 Item Quick Inventory of Depressive Symptomatology Self-Report Version (QIDS-SR16) in military veterans with PTSD. Journal of Affective Disorders 202, pages 16-22.
Crossref
Heidi Ormstad, Johan Dahl, Robert Verkerk, Ole A. Andreassen & Michael Maes. (2016) Increased plasma levels of competing amino acids, rather than lowered plasma tryptophan levels, are associated with a non-response to treatment in major depression. European Neuropsychopharmacology 26:8, pages 1286-1296.
Crossref
Olivier Doumy, Djamila Bennabi, Wissam El-Hage, Najib Allaïli, Rémy Bation, Frank Bellivier, Jérôme Holtzmann, Maxime Bubrovszky, Vincent Camus, Thomas Charpeaud, Pierre Courvoisier, Thierry d’Amato, Marion Garnier, Frédéric Haesebaert, Thierry Bougerol, Christophe Lançon, Fanny Moliere, Isabel Nieto, Raphaëlle Richieri, Ghassen Saba, Philippe Courtet, Guillaume Vaiva, Marion Leboyer, Pierre-Michel Llorca, Bruno Aouizerate & Emmanuel Haffen. (2016) Dépression résistante : les stratégies de potentialisation. La Presse Médicale 45:3, pages 338-349.
Crossref
M Bauer, S Berman, T Stamm, M Plotkin, M Adli, M Pilhatsch, E D London, G S Hellemann, P C Whybrow & F Schlagenhauf. (2015) Levothyroxine effects on depressive symptoms and limbic glucose metabolism in bipolar disorder: a randomized, placebo-controlled positron emission tomography study. Molecular Psychiatry 21:2, pages 229-236.
Crossref
Meinhard Kieser & Kathrin Stucke. (2016) Assessing additional benefit in noninferiority trials. Biometrical Journal 58:1, pages 154-169.
Crossref
Hyun-Ja Jeong, Jeong-Hwa Kim, Na-Rae Kim, Myoung-schook Yoou, Sun-Young Nam, Kyu-Youb Kim, Youngjin Choi, Jae-Bum Jang, In-Cheol Kang, Nam-In Baek & Hyung-Min Kim. (2014) Antidepressant effect of Stillen™. Archives of Pharmacal Research 38:6, pages 1223-1231.
Crossref
Anthony Cleare, CM Pariante, AH Young, IM Anderson, D Christmas, PJ Cowen, C Dickens, IN Ferrier, J Geddes, S Gilbody, PM Haddad, C Katona, G Lewis, A Malizia, RH McAllister-Williams, P Ramchandani, J Scott, D Taylor & R Uher. (2015) Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology 29:5, pages 459-525.
Crossref
Michael Bauer, Michael E Thase, Sherry Liu, Willie Earley & Hans Eriksson. (2014) Analysis of potentially predictive factors of efficacy of adjunct extended-release quetiapine fumarate in patients with major depressive disorder. Journal of Psychopharmacology 29:5, pages 565-574.
Crossref
Gilles Ambresin, Victoria Palmer, Konstancja Densley, Christopher Dowrick, Gail Gilchrist & Jane M Gunn. (2015) What factors influence long-term antidepressant use in primary care? Findings from the Australian diamond cohort study. Journal of Affective Disorders 176, pages 125-132.
Crossref
Maryna Polyakova, Katharina Stuke, Katharina Schuemberg, Karsten Mueller, Peter Schoenknecht & Matthias L. Schroeter. (2015) BDNF as a biomarker for successful treatment of mood disorders: A systematic & quantitative meta-analysis. Journal of Affective Disorders 174, pages 432-440.
Crossref
Martin Bares, Tomas Novak, Miloslav Kopecek, Martin Brunovsky, Pavla Stopkova & Cyril Höschl. (2014) The effectiveness of prefrontal theta cordance and early reduction of depressive symptoms in the prediction of antidepressant treatment outcome in patients with resistant depression: analysis of naturalistic data. European Archives of Psychiatry and Clinical Neuroscience 265:1, pages 73-82.
Crossref
Chi-Un Pae. (2015) Evidence-Based Treatment for Depressive Disorder. Psychiatry Investigation 12:2, pages 278.
Crossref
Johannes Beck, Nicole Bruni, Serge Brand & Edith Holsboer-Trachsler. (2015) Repeated Cortisol Awakening Response as Predictor of Antidepressant Treatment Outcome with Duloxetine. Neuropsychobiology 71:2, pages 97-102.
Crossref
Thomas J. Reilly, Steve A. MacGillivray, Ian C. Reid & Isobel M. Cameron. (2015) Psychometric properties of the 16-item Quick Inventory of Depressive Symptomatology: A systematic review and meta-analysis. Journal of Psychiatric Research 60, pages 132-140.
Crossref
. 2015. Therapie Psychischer Erkrankungen. Therapie Psychischer Erkrankungen e1 e96 .
Tom Bschor, Michael Bauer & Mazda Adli. (2014) Chronic and Treatment Resistant Depression. Deutsches Ärzteblatt international.
Crossref
. (2014) Consider using lithium to augment antidepressant therapy or as a preventative maintenance therapy in patients with major depressive disorder. Drugs & Therapy Perspectives 30:11, pages 386-389.
Crossref
Jeong Seok Seo, Hoo Rim Song, Hwang Bin Lee, Young-Min Park, Jeong-Wan Hong, Won Kim, Hee-Ryung Wang, Eun-Sung Lim, Jong-Hyun Jeong, Duk-In Jon, Kyung Joon Min, Young Sup Woo & Won-Myong Bahk. (2014) The Korean medication algorithm for depressive disorder: Second revision. Journal of Affective Disorders 167, pages 312-321.
Crossref
Florian Seemüller, Sebastian Meier, Michael Obermeier, Richard Musil, Michael Bauer, Mazda Adli, Klaus Kronmüller, Florian Holsboer, Peter Brieger, Gerd Laux, Wolfram Bender, Isabella Heuser, Joachim Zeiler, Wolfgang Gaebel, Michael Riedel, Peter Falkai & Hans-Jürgen Möller. (2014) Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors. European Archives of Psychiatry and Clinical Neuroscience 264:7, pages 567-575.
Crossref
Tingting Yan, Lijuan Wang, Weihong Kuang, Jiajun Xu, Suping Li, Jie Chen & Yanchun Yang. (2014) Brain-derived neurotrophic factor Val66Met polymorphism association with antidepressant efficacy: A systematic review and meta-analysis. Asia-Pacific Psychiatry 6:3, pages 241-251.
Crossref
Isobel M. Cameron, Ian C. Reid & Steve A. MacGillivray. (2014) Efficacy and tolerability of antidepressants for sub-threshold depression and for mild major depressive disorder. Journal of Affective Disorders 166, pages 48-58.
Crossref
Stuart A. Montgomery, Rebecca Z. Nielsen, Lis H. Poulsen & Lars Häggström. (2014) A randomised, double‐blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Human Psychopharmacology: Clinical and Experimental 29:5, pages 470-482.
Crossref
J. E. Sinclair, L. S. Aucott, K. Lawton, I. C. Reid & I. M. Cameron. (2014) The monitoring of longer term prescriptions of antidepressants: observational study in a primary care setting. Family Practice 31:4, pages 419-426.
Crossref
Andreas Hahn, Daniela Haeusler, Christoph Kraus, Anna S. Höflich, Georg S. Kranz, Pia Baldinger, Markus Savli, Markus Mitterhauser, Wolfgang Wadsak, Georgios Karanikas, Siegfried Kasper & Rupert Lanzenberger. (2014) Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression. Human Brain Mapping 35:8, pages 3857-3866.
Crossref
H.-J. Möller, F. Seemüller, R. Schennach-Wolff, S. Stübner, E. Rüther & R. Grohmann. (2013) History, background, concepts and current use of comedication and polypharmacy in psychiatry. The International Journal of Neuropsychopharmacology 17:07, pages 983-996.
Crossref
Li Wen, Yahong Jin, Lei Li, Shuangyu Sun, Shixiang Cheng, Sai Zhang, Yong Zhang & Per Svenningsson. (2014) Exercise prevents raphe nucleus mitochondrial overactivity in a rat depression model. Physiology & Behavior 132, pages 57-65.
Crossref
Tom Bschor. (2014) Lithium in the Treatment of Major Depressive Disorder. Drugs 74:8, pages 855-862.
Crossref
Ellen Piek, Boudewijn J. Kollen, Klaas van der Meer, Brenda W. J. H. Penninx & Willem A. Nolen. (2014) Maintenance Use of Antidepressants in Dutch General Practice: Non-Guideline Concordant. PLoS ONE 9:5, pages e97463.
Crossref
Michael Bauer, Mazda Adli, Roland Ricken, Emanuel Severus & Maximilian Pilhatsch. (2014) Role of Lithium Augmentation in the Management of Major Depressive Disorder. CNS Drugs 28:4, pages 331-342.
Crossref
Andrew A Nierenberg, Louisa G Sylvia, Andrew C LeonNoreen A Reilly-Harrington, Leah W Shesler, Susan L McElroy, Edward S Friedman, Michael E Thase, Richard C Shelton, Charles L Bowden, Mauricio Tohen, Vivek Singh, Thilo Deckersbach, Terence A Ketter, James H Kocsis, Melvin G McInnis, David Schoenfeld, William V Bobo & Joseph R Calabrese. (2013) Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): A pragmatic trial of complex treatment for a complex disorder. Clinical Trials 11:1, pages 114-127.
Crossref
Pauline Turner, Rakesh Kantaria & Allan H Young. (2013) A systematic review and meta-analysis of the evidence base for add-on treatment for patients with major depressive disorder who have not responded to antidepressant treatment: A European perspective. Journal of Psychopharmacology 28:2, pages 85-98.
Crossref
Pim Cuijpers, Marit Sijbrandij, Sander L. Koole, Gerhard Andersson, Aartjan T. Beekman & Charles F. ReynoldsIIIIII. (2014) Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry 13:1, pages 56-67.
Crossref
Hee Ryung WangWon-Myong BahkYoung-Min ParkHwang Bin LeeHoo Rim SongJong-Hyun JeongJeong Seok SeoEun-Sung LimJeong-Wan HongWon KimDuk-In JonJin-Pyo HongYoung Sup WooKyung Joon Min. (2014) Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines. Psychiatry Investigation 11:1, pages 1.
Crossref
Eunsoo Won, Seon-Cheol Park, Kyu-Man Han, Seung-Hwan Sung, Hwa-Young Lee, Jong-Woo Paik, Hong Jin Jeon, Moon-Soo Lee, Se-Hoon Shim, Young-Hoon Ko, Kang-Joon Lee, Changsu Han, Byung-Joo Ham, Joonho Choi, Tae-Yeon Hwang, Kang-Seob Oh, Sang-Woo Hahn, Yong-Chon Park & Min-Soo Lee. (2014) Evidence-Based, Pharmacological Treatment Guideline for Depression in Korea, Revised Edition. Journal of Korean Medical Science 29:4, pages 468.
Crossref
Takashi IKUTA. (2014) A New Type of Depression Identified in Clinical Practice. Journal of Occupational Safety and Health 7:1, pages 13-21.
Crossref
Shunpei Moriya, Yu Tahara, Hiroyuki Sasaki, Yutaro Hamaguchi, Daisuke Kuriki, Ryosuke Ishikawa, Jun Ishigooka & Shigenobu Shibata. (2014) Effect of Quetiapine on Per1, Per2, and Bmal1 Clock Gene Expression in the Mouse Amygdala and Hippocampus. Journal of Pharmacological Sciences 125:3, pages 329-332.
Crossref
Christoph Kraus, Sebastian Ganger, Jan Losak, Andreas Hahn, Markus Savli, Georg S. Kranz, Pia Baldinger, Christian Windischberger, Siegfried Kasper & Rupert Lanzenberger. (2014) Gray matter and intrinsic network changes in the posterior cingulate cortex after selective serotonin reuptake inhibitor intake. NeuroImage 84, pages 236-244.
Crossref
. 2014. Therapie Psychischer Erkrankungen. Therapie Psychischer Erkrankungen 1 91 .
Jin Mizushima, Hitoshi Sakurai, Yuya Mizuno, Masaki Shinfuku, Hideaki Tani, Kadunari Yoshida, Chisa Ozawa, Asako Serizawa, Natsuko Kodashiro, Shinya Koide, Atsumi Minamisawa, Eisaku Mutsumoto, Nobuhiro Nagai, Sachiko Noda, Genichiro Tachino, Tatsuichiro Takahashi, Hiroyoshi Takeuchi, Toshiaki Kikuchi, Hiroyuki Uchida, Koichiro Watanabe, Hiroki Kocha & Masaru Mimura. (2013) Melancholic and reactive depression: a reappraisal of old categories. BMC Psychiatry 13:1.
Crossref
Hee-Ju Kang, Jae-Min Kim, Ju-Yeon Lee, Seon-Young Kim, Kyung-Yeol Bae, Sung-Wan Kim, Il-Seon Shin, Hye-Ran Kim, Myung-Geun Shin & Jin-Sang Yoon. (2013) BDNF promoter methylation and suicidal behavior in depressive patients. Journal of Affective Disorders 151:2, pages 679-685.
Crossref
Gian Marco Leggio, Salvatore Salomone, Claudio Bucolo, Chiara Platania, Vincenzo Micale, Filippo Caraci & Filippo Drago. (2013) Dopamine D3 receptor as a new pharmacological target for the treatment of depression. European Journal of Pharmacology 719:1-3, pages 25-33.
Crossref
M. Köster, R. Grohmann, R. R. Engel, M. A. Nitsche, E. Rüther & D. Degner. (2013) Seizures during antidepressant treatment in psychiatric inpatients—results from the transnational pharmacovigilance project “Arzneimittelsicherheit in der Psychiatrie” (AMSP) 1993–2008. Psychopharmacology 230:2, pages 191-201.
Crossref
Michael Bauer, Liliana Dell'Osso, Siegfried Kasper, William Pitchot, Eva Dencker Vansvik, Jürgen Köhler, Leif Jørgensen & Stuart A. Montgomery. (2013) Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder. Journal of Affective Disorders 151:1, pages 209-219.
Crossref
Nenad Jakšić, Ena Ivezić, Nataša Jokić-Begić, Zsuzsanna Surányi & Stanislava Stojanović-Špehar. (2013) Factorial and Diagnostic Validity of the Beck Depression Inventory-II (BDI-II) in Croatian Primary Health Care. Journal of Clinical Psychology in Medical Settings 20:3, pages 311-322.
Crossref
Elnaz Ostad Haji, Stefanie Wagner, Mirijam Fric, Gerd Laux, Patrick Pittermann, Joachim Röschke & Christoph Hiemke. (2013) Quetiapine and Norquetiapine Serum Concentrations and Clinical Effects in Depressed Patients Under Augmentation Therapy With Quetiapine. Therapeutic Drug Monitoring 35:4, pages 539-545.
Crossref
Massimiliano Buoli, Alice Caldiroli & Alfredo Carlo Altamura. (2013) Psychotic versus non-psychotic major depressive disorder: A comparative naturalistic study. Asian Journal of Psychiatry 6:4, pages 333-337.
Crossref
Richard Musil, Peter Zill, Florian Seemüller, Brigitta Bondy, Michael Obermeier, Ilja Spellmann, Wolfram Bender, Mazda Adli, Isabella Heuser, Joachim Zeiler, Wolfgang Gaebel, Wolfgang Maier, Marcella Rietschel, Dan Rujescu, Rebecca Schennach, Hans-Jürgen Möller & Michael Riedel. (2012) No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression. European Archives of Psychiatry and Clinical Neuroscience 263:5, pages 405-412.
Crossref
Hee-Ju Kang, Jae-Min Kim, Robert Stewart, Seon-Young Kim, Kyung-Yeol Bae, Sung-Wan Kim, Il-Seon Shin, Myung-Geun Shin & Jin-Sang Yoon. (2013) Association of SLC6A4 methylation with early adversity, characteristics and outcomes in depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 44, pages 23-28.
Crossref
Richard Musil, Peter Zill, Florian Seemüller, Brigitta Bondy, Sebastian Meyer, Ilja Spellmann, Wolfram Bender, Mazda Adli, Isabella Heuser, Robert Fisher, Wolfgang Gaebel, Wolfgang Maier, Marcella Rietschel, Dan Rujescu, Rebecca Schennach, Hans-Jürgen Möller & Michael Riedel. (2013) Genetics of emergent suicidality during antidepressive treatment—Data from a naturalistic study on a large sample of inpatients with a major depressive episode. European Neuropsychopharmacology 23:7, pages 663-674.
Crossref
Héloïse Delavenne, Frederico Duarte Garcia & Florence Thibaut. (2013) Les médicaments antidépresseurs influencent-ils les passages à l’acte auto- et hétéroagressifs ?. La Presse Médicale 42:6, pages 968-976.
Crossref
Pim Cuijpers, Marit Sijbrandij, Sander L. Koole, Gerhard Andersson, Aartjan T. Beekman & Charles F. ReynoldsIIIIII. (2013) The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta‐analysis of direct comparisons. World Psychiatry 12:2, pages 137-148.
Crossref
Isobel M. Cameron, John R. Crawford, Amanda H. Cardy, Schalk W. du Toit, Kenneth Lawton, Steven Hay, Kenneth Mitchell, Sumit Sharma, Shilpa Shivaprasad, Sally Winning & Ian C. Reid. (2013) Psychometric properties of the Quick Inventory of Depressive Symptomatology (QIDS-SR) in UK primary care. Journal of Psychiatric Research 47:5, pages 592-598.
Crossref
Sidney Chocron, Pierre Vandel, Camille Durst, Frédéric Laluc, Djamel Kaili, Michael Chocron & Joseph-Philippe Etievent. (2013) Antidepressant Therapy in Patients Undergoing Coronary Artery Bypass Grafting: The MOTIV-CABG Trial. The Annals of Thoracic Surgery 95:5, pages 1609-1618.
Crossref
Ashwin A. Patkar & Chi-Un Pae. (2013) Atypical Antipsychotic Augmentation Strategies in the Context of Guideline-based Care for the Treatment of Major Depressive Disorder. CNS Drugs 27:S1, pages 29-37.
Crossref
Chia-Ming Chang, Soichiro Sato & Changsu Han. (2013) Evidence for the Benefits of Nonantipsychotic Pharmacological Augmentation in the Treatment of Depression. CNS Drugs 27:S1, pages 21-27.
Crossref
Siegfried Kasper & Stuart MontgomeryRobert Haußmann & Michael Bauer. 2013. Treatment‐resistant Depression. Treatment‐resistant Depression 129 157 .
Siegfried Kasper & Stuart MontgomerySiegfried Kasper & Elena Akimova. 2013. Treatment‐resistant Depression. Treatment‐resistant Depression 107 128 .
Siegfried Kasper & Stuart MontgomeryDaniel Souery & William Pitchot. 2013. Treatment‐resistant Depression. Treatment‐resistant Depression 1 20 .
Andreas Hahn, Lukas Nics, Pia Baldinger, Wolfgang Wadsak, Markus Savli, Christoph Kraus, Wolfgang Birkfellner, Johanna Ungersboeck, Daniela Haeusler, Markus Mitterhauser, Georgios Karanikas, Siegfried Kasper, Richard Frey & Rupert Lanzenberger. (2013) Application of image-derived and venous input functions in major depression using [carbonyl-11C]WAY-100635. Nuclear Medicine and Biology 40:3, pages 371-377.
Crossref
I. Gilaberte, I. Romera, V. Perez-Sola, J.M. Menchon & A. Schacht. (2013) Different levels of lack of improvement at 4 weeks of escitalopram treatment as predictors of poor 8-week outcome in MDD. Journal of Affective Disorders 146:3, pages 433-437.
Crossref
Raphaëlle Richieri, Marc Adida, Laurent Boyer & Christophe Lançon. (2013) Psychostimulants dans le traitement de la dépression. La Presse Médicale 42:3, pages 347-352.
Crossref
Aurélie Bocquier, Sébastien Cortaredona, Hélène Verdoux, Vincent Sciortino, Stève Nauleau & Pierre Verger. (2013) Social inequalities in new antidepressant treatment: a study at the individual and neighborhood levels. Annals of Epidemiology 23:3, pages 99-105.
Crossref
Stephan Köhler, Sabine Hoffmann, Theresa Unger, Bruno Steinacher, Nicholas Dierstein & Thomas Fydrich. (2011) Effectiveness of Cognitive–Behavioural Therapy Plus Pharmacotherapy in Inpatient Treatment of Depressive Disorders. Clinical Psychology & Psychotherapy 20:2, pages 97-106.
Crossref
Kyu-Man HanSeon-Cheol ParkEun-Soo WonSeung-Hwan SungHeeyoung LeeJae-Woo KooKyungmin LeeHwa-Young LeeJong-Woo PaikHong Jin JeonMoon-Soo LeeSe-Hoon ShimYoung-Hoon KoKang-Joon LeeChangsu HanByung-Joo HamJoonho ChoiTae-Yeon HwangKang-Seob OhSang-Woo HahnYong-Chon ParkMin-Soo Lee. (2013) Evidence-Based Korean Pharmacological Treatment Guideline for Depression, Revised Edition (III) : Dose Increment, Switching, Combination, and Augmentation Strategy in Antidepressant Therapy. Journal of Korean Neuropsychiatric Association 52:5, pages 386.
Crossref
Seung-Hwan SungSeon-Cheol ParkKyu-Man HanEun-Soo WonHwa-Young LeeJae-Woo KooJong-Woo PaikKyung-Min LeeHong Jin JeonMoon-Soo LeeSe-Hoon ShimYoung-Hoon KoKang-Joon LeeChangsu HanByung-Joo HamJoonho ChoiTae-Yeon HwangKang-Seob OhYong-Chon ParkMin-Soo LeeSang-Woo Hahn. (2013) Evidence-Based Korean Pharmacological Treatment Guideline for Depression, Revised Edition (II) : Antidepressant Efficacy Compared with Placebo, Difference in Efficacy of Antidepressants, and Appropriate Time of Efficacy Judgment in Antidepressant Therapy. Journal of Korean Neuropsychiatric Association 52:5, pages 372.
Crossref
Seon-Cheol ParkSeung-Hwan SungKyu-Man HanEun-Soo WonHwa-Young LeeJong-Woo PaikHong Jin JeonMoon-Soo LeeSe-Hoon ShimYoung-Hoon KoKang-Joon LeeChangsu HanByung-Joo HamJoonho ChoiHeeyoung LeeTae-Yeon HwangKang-Seob OhYong-Chon ParkMin-Soo LeeSang-Woo Hahn. (2013) Evidence-Based Korean Pharmacological Treatment Guideline for Depression, Revised Edition (I) : Initial Choice of Antidepressant Treatment. Journal of Korean Neuropsychiatric Association 52:4, pages 253.
Crossref
R Lanzenberger, P Baldinger, A Hahn, J Ungersboeck, M Mitterhauser, D Winkler, Z Micskei, P Stein, G Karanikas, W Wadsak, S Kasper & R Frey. (2012) Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET. Molecular Psychiatry 18:1, pages 93-100.
Crossref
Richard M. O'Connor, Matteo M. Pusceddu, Olivia F. O'Leary, Helene M. Savignac, Javier A. Bravo, Malika El Yacoubi, Jean-Marie Vaugeois, Timothy G. Dinan & John F. Cryan. (2013) Hippocampal group III mGlu receptor mRNA levels are not altered in specific mouse models of stress, depression and antidepressant action. Pharmacology Biochemistry and Behavior 103:3, pages 561-567.
Crossref
Fábio Lopes Rocha, Cíntia Fuzikawa, Rachel Riera, Melissa Guarieiro Ramos & Cláudia Hara. (2013) Antidepressant combination for major depression in incomplete responders—a systematic review. Journal of Affective Disorders 144:1-2, pages 1-6.
Crossref
Sohita Dhillon. (2012) Duloxetine. Drugs & Aging 30:1, pages 59-79.
Crossref
Stefan Schwarz & Lutz Frölich. 2013. Drug Therapy for the Elderly. Drug Therapy for the Elderly 197 213 .
Emanuel Severus & Michael Bauer. 2013. Ethik psychiatrischer Forschung. Ethik psychiatrischer Forschung 185 192 .
Ulrich-Michael Hemmeter. 2013. Burnout for Experts. Burnout for Experts 73 87 .
Ross J. BaldessariniRoss J. Baldessarini. 2013. Chemotherapy in Psychiatry. Chemotherapy in Psychiatry 155 250 .
T. Bschor, J. Angst, J.M. Azorin, C.L. Bowden, G. Perugi, E. Vieta, A.H. Young & S. Krüger. (2012) Are bipolar disorders underdiagnosed in patients with depressive episodes? Results of the multicenter BRIDGE screening study in Germany. Journal of Affective Disorders 142:1-3, pages 45-52.
Crossref
Andrea Fagiolini, Alessandro Comandini, Mario Catena Dell’Osso & Siegfried Kasper. (2012) Rediscovering Trazodone for the Treatment of Major Depressive Disorder. CNS Drugs 26:12, pages 1033-1049.
Crossref
Martin Lieb, Rainer Rupprecht & Thomas C. Baghai. (2012) Für jeden Patienten den optimalen Wirkstoff finden. NeuroTransmitter 23:12, pages 26-38.
Crossref
Maya Schwartz-Lifshitz, Gil Zalsman, Lucas Giner & Maria A. Oquendo. (2012) Can We Really Prevent Suicide?. Current Psychiatry Reports 14:6, pages 624-633.
Crossref
R. E. Lawrence, K. A. Rasinski, J. D. Yoon, K. G. Meador, H. G. Koenig & F. A. Curlin. (2012) Primary care physicians’ and psychiatrists’ approaches to treating mild depression. Acta Psychiatrica Scandinavica 126:5, pages 385-392.
Crossref
M. Bares, T. Novak, M. Kopecek, P. Stopkova, J. Kozeny & C. Höschl. (2020) The early improvement of depressive symptoms as a potential predictor of response to antidepressants in depressive patients who failed to respond to previous antidepressant treatments. Analysis of naturalistic data. European Psychiatry 27:7, pages 522-527.
Crossref
F. Seemüller, M. Riedel, M. Obermeier, R. Schennach-Wolff, I. Spellmann, S. Meyer, M. Bauer, M. Adli, K. Kronmüller, M. Ising, P. Brieger, G. Laux, W. Bender, I. Heuser, J. Zeiler, W. Gaebel & H.-J. Möller. (2020) The validity of self-rated psychotic symptoms in depressed inpatients. European Psychiatry 27:7, pages 547-552.
Crossref
Anusha Baskaran, Roumen Milev & Roger S. McIntyre. (2012) The neurobiology of the EEG biomarker as a predictor of treatment response in depression. Neuropharmacology 63:4, pages 507-513.
Crossref
Cássio M. C. Bottino, Ricardo Barcelos-Ferreira & Salma R. I. Ribeiz. (2012) Treatment of Depression in Older Adults. Current Psychiatry Reports 14:4, pages 289-297.
Crossref
Siegfried Kasper, Bjarke Ebert, Klaus Larsen & Brigitte Tonnoir. (2011) Combining escitalopram with gaboxadol provides no additional benefit in the treatment of patients with severe major depressive disorder. The International Journal of Neuropsychopharmacology 15:06, pages 715-725.
Crossref
Alexandra Schosser, Alessandro Serretti, Daniel Souery, Julien Mendlewicz, Joseph Zohar, Stuart Montgomery & Siegfried Kasper. (2012) European Group for the Study of Resistant Depression (GSRD) — Where have we gone so far: Review of clinical and genetic findings. European Neuropsychopharmacology 22:7, pages 453-468.
Crossref
Hans-Jürgen Möller. (2011) How close is evidence to truth in evidence-based treatment of mental disorders?. European Archives of Psychiatry and Clinical Neuroscience 262:4, pages 277-289.
Crossref
Thomas E Schlaepfer, Hans Ågren, Palmiero Monteleone, Cristobal Gasto, William Pitchot, Frederick Rouillon, David J Nutt & Siegfried Kasper. (2012) The hidden third: improving outcome in treatment-resistant depression. Journal of Psychopharmacology 26:5, pages 587-602.
Crossref
A. Konstantinidis, K. Papageorgiou, R. Grohmann, A. Horvath, R. Engel & S. Kasper. (2011) Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program. The International Journal of Neuropsychopharmacology 15:04, pages 449-457.
Crossref
Ulrich Hegerl, Antje-Kathrin Allgaier, Verena Henkel & Roland Mergl. (2012) Can effects of antidepressants in patients with mild depression be considered as clinically significant?. Journal of Affective Disorders 138:3, pages 183-191.
Crossref
Zhi Xu, Zhijun Zhang, Yanyan Shi, Mengjia Pu, Yonggui Yuan, Xiangrong Zhang, Lingjiang Li & Gavin P Reynolds. (2011) Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response. Journal of Psychopharmacology 26:3, pages 349-359.
Crossref
Jung-Ah Min, Na-Bin Lee, Chang-Uk Lee, Chul Lee & Jeong-Ho Chae. (2012) Low trait anxiety, high resilience, and their interaction as possible predictors for treatment response in patients with depression. Journal of Affective Disorders 137:1-3, pages 61-69.
Crossref

Displaying 200 of 273 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.